{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T18:44:29Z","timestamp":1746816269616},"reference-count":68,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2011.0771","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:20:20Z","timestamp":1525252820000},"source":"Crossref","is-referenced-by-count":4,"title":["Vaccination Recommendations for Germany"],"prefix":"10.3238","author":[{"given":"Miriam","family":"Wiese-Posselt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Tertilt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2011,11,11]]},"reference":[{"key":"10.3238\/arztebl.2011.0771_ref1","unstructured":"Plotkin S, Orenstein W, Offit P: Vaccines. Saunders Elsevier 2008, 5th Edition: 1573\u201380."},{"key":"10.3238\/arztebl.2011.0771_ref2","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2011. Epid Bulletin 30\/2011: 275\u201394."},{"key":"10.3238\/arztebl.2011.0771_ref3","doi-asserted-by":"crossref","unstructured":"Roush SW, Murphy TV, Vaccine-Preventable Disease Table Working Group: Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007; 298: 2155\u201363.","DOI":"10.1001\/jama.298.18.2155"},{"key":"10.3238\/arztebl.2011.0771_ref4","doi-asserted-by":"crossref","unstructured":"Hellenbrand W, Beier D, Jensen E, et al.: The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009; 9: 22.","DOI":"10.1186\/1471-2334-9-22"},{"key":"10.3238\/arztebl.2011.0771_ref5","doi-asserted-by":"crossref","unstructured":"R\u00fcckinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, Siedler A: Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 2009; 27: 4136\u201341.","DOI":"10.1016\/j.vaccine.2009.04.057"},{"key":"10.3238\/arztebl.2011.0771_ref6","unstructured":"Stellungnahme der Deutschen Akademie f\u00fcr Kinder- und Jugendmedizin e. V.: \u00dcberwachung der Atmung bei ehemaligen Fr\u00fchgeborenen ("},{"key":"10.3238\/arztebl.2011.0771_ref7","doi-asserted-by":"crossref","unstructured":"Zepp F, Heininger U, Mertsola J, et al.: Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11: 557\u201370.","DOI":"10.1016\/S1473-3099(11)70007-X"},{"key":"10.3238\/arztebl.2011.0771_ref8","doi-asserted-by":"crossref","unstructured":"Booy R, Van der Meeren O, Ng SP, Celzo F, Ramakrishnan G, Jacquet JM: A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix\u2122) is immunogenic and well tolerated in adults. Vaccine 2010; 29(1): 45\u201350.","DOI":"10.1016\/j.vaccine.2010.10.025"},{"key":"10.3238\/arztebl.2011.0771_ref9","doi-asserted-by":"crossref","unstructured":"Beytout J, Launay O, Guiso N, et al.: Safety of Tdap-IPV given 1 month after Td-IPV booster in healthy young adults: a placebo-controlled trial. Human Vaccines 2009; 5(5): 315\u201321.","DOI":"10.4161\/hv.5.5.6911"},{"key":"10.3238\/arztebl.2011.0771_ref10","unstructured":"WHO: . Regional Committee for Europe. Sixtieth session Moscow, 13\u201316 September 2010."},{"key":"10.3238\/arztebl.2011.0771_ref11","doi-asserted-by":"crossref","unstructured":"Wicker S, Rabenau HF, Gottschalk R, Doerr HW, Allwinn R: Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 2007; 196(3): 145\u201350.","DOI":"10.1007\/s00430-007-0036-3"},{"key":"10.3238\/arztebl.2011.0771_ref12","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: Pneumokokken-Polysaccharid-Impfung \u2013 Anpassung der Empfehlung und Begr\u00fcndung. Epid Bulletin 32\/2009: 337\u20138."},{"key":"10.3238\/arztebl.2011.0771_ref13","doi-asserted-by":"crossref","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S: Human papillomavirus and cervical cancer. Lancet 2007; (370): 890\u2013907.","DOI":"10.1016\/S0140-6736(07)61416-0"},{"key":"10.3238\/arztebl.2011.0771_ref14","doi-asserted-by":"crossref","unstructured":"Zur Hausen H: Papillomaviruses in the causation of human cancers \u2013 a brief historical account. Virology 2009; 384 (2): 260\u20135.","DOI":"10.1016\/j.virol.2008.11.046"},{"key":"10.3238\/arztebl.2011.0771_ref15","unstructured":"Gerhardus A: Wie wirksam ist die HPV-Impfung? Dtsch Arztebl 2009; 106(8): A 330\u20134."},{"key":"10.3238\/arztebl.2011.0771_ref16","doi-asserted-by":"crossref","unstructured":"Dillner J and the FUTURE I\/II Study Group: Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomized controlled trial. BMJ 2010; 341: 3493.","DOI":"10.1136\/bmj.c3493"},{"key":"10.3238\/arztebl.2011.0771_ref17","doi-asserted-by":"crossref","unstructured":"Paavonen J, HPV PATRICIA Study Group: Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374: 301\u20134.","DOI":"10.1016\/S0140-6736(09)61248-4"},{"key":"10.3238\/arztebl.2011.0771_ref18","unstructured":"Romanowski B: Efficacy of the HPV-16\/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types: end of-study results. Ab-stract and oral presentation on IPvC, Montr\u00e9al, 2010."},{"key":"10.3238\/arztebl.2011.0771_ref19","unstructured":"Koch J, Wiese-Posselt M: Epidemiology of rotavirus infections in children"},{"key":"10.3238\/arztebl.2011.0771_ref20","doi-asserted-by":"crossref","unstructured":"Vesikari T, Matson DO, Dennehy P, et al.: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006; 354(1): 23\u201333.","DOI":"10.1056\/NEJMoa052664"},{"key":"10.3238\/arztebl.2011.0771_ref21","doi-asserted-by":"crossref","unstructured":"Ruiz-Palacios GM, P\u00e9rez-Schael I, Vel\u00e1zquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006; 354(1): 11\u201322.","DOI":"10.1056\/NEJMoa052434"},{"key":"10.3238\/arztebl.2011.0771_ref22","doi-asserted-by":"crossref","unstructured":"Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H: Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children. Pediatr Infect Dis J. 2010; 29 (4): 319\u201323.","DOI":"10.1097\/INF.0b013e3181c18434"},{"key":"10.3238\/arztebl.2011.0771_ref23","unstructured":"Oberle D, Weisser K, Keller-Stanislawski B: Aktuelle Erkenntnisse zum Risiko f\u00fcr Invagination und Kawasaki-Syndrom nach Rotavirusimpfung. Bulletin zur Arzneimittelsicherheit \u2013 Informationen aus BfArM und PEI. ."},{"key":"10.3238\/arztebl.2011.0771_ref24","unstructured":"Centers for Disease Control and Prevention: . Morbidity and Mortality Weekly Report (MMWR) 2011; 60(41): 1427."},{"key":"10.3238\/arztebl.2011.0771_ref25","doi-asserted-by":"crossref","unstructured":"Jit M, Mangen MJ, Elliez H, et al.: An update to \u201cThe cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe\u201d. Vaccine 2010; 28(47): 7457\u20139.","DOI":"10.1016\/j.vaccine.2010.08.060"},{"key":"10.3238\/arztebl.2011.0771_ref26","doi-asserted-by":"crossref","unstructured":"Schneewei\u00df B, Pfleiderer M, Keller-Stanislawski, B-I: Vaccination Safety Update Dtsch Arztebl 2008; 105(34\u201335): 590\u20135.","DOI":"10.3238\/arztebl.2008.0590"},{"key":"10.3238\/arztebl.2011.0771_ref27","doi-asserted-by":"crossref","unstructured":"Schmitz R, Poethko-M\u00fcller C, Reiter S, Schlaud M: Vaccination status and health in children and adolescents\u2014findings of the German health interview and examination survey for children and adolescents (KiGGS). Dtsch Arztebl Int 2011; 108(7): 99\u2013104.","DOI":"10.3238\/arztebl.2011.0099"},{"key":"10.3238\/arztebl.2011.0771_ref28","doi-asserted-by":"crossref","unstructured":"Dutta A: Epidemiology of poliomyelitis\u2013Options and update. Vaccine 2008; 26(45): 5767\u20135773.","DOI":"10.1016\/j.vaccine.2008.07.101"},{"key":"10.3238\/arztebl.2011.0771_ref29","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: Empfehlung der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut zur Pertussis-Schutzimpfung Stand: Januar 2006. Epid Bulletin 3\/2006: 21\u201323."},{"key":"10.3238\/arztebl.2011.0771_ref30","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut: Impfung gegen Neue Influenza A (H1N1). Epid Bulletin 41\/2009: 403\u2013424."},{"key":"10.3238\/arztebl.2011.0771_ref31","doi-asserted-by":"crossref","unstructured":"Markina SS, Maksimova NM, Vitek CR, Bogatyreva EY, Monisov AA: Diphtheria in the Russian Federation in the 1990s. J Infect Dis 2000; 181: 27\u201334.","DOI":"10.1086\/315535"},{"key":"10.3238\/arztebl.2011.0771_ref32","unstructured":"Robert Koch-Institut: Infektionsepidemiologisches Jahrbuch 2001\u20132009. > Infektionsschutz > Infektionsepi. Jahrbuch > Jahrb\u00fccher."},{"key":"10.3238\/arztebl.2011.0771_ref33","unstructured":"Robert Koch-Institut: Tetanus: Ratgeber Infektionskrankheiten \u2013 Merkbl\u00e4tter f\u00fcr \u00c4rzte (Stand: M\u00e4rz 2010). > Infektionskrankheiten A-Z > Tetanus."},{"key":"10.3238\/arztebl.2011.0771_ref34","unstructured":"Weltgesundheitsorganisation (WHO): Vaccine preventable diseases: ."},{"key":"10.3238\/arztebl.2011.0771_ref35","unstructured":"Erhebungseinheit f\u00fcr seltene p\u00e4diatrische Erkrankungen in Deutschland (ESPED): ESPED-Jahresberichte 2006 & 2007. > Berichte."},{"key":"10.3238\/arztebl.2011.0771_ref36","doi-asserted-by":"crossref","unstructured":"Pilishvili T, Lexau C, Farley M M, et al.: Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. JID 2010; 201(1): 32\u201341.","DOI":"10.1086\/648593"},{"key":"10.3238\/arztebl.2011.0771_ref37","unstructured":"Scholz H, Lang T, Repp R, Rieske K, Wirth S: Hepaitis B. In: Deutsche Gesellschaft f\u00fcr p\u00e4diatrische Infektiologie (Hrsg.): Handbuch Infektionen bei Kindern und Jugendlichen. M\u00fcnchen: Futuramed-Verlag 2000; 322."},{"key":"10.3238\/arztebl.2011.0771_ref38","doi-asserted-by":"crossref","unstructured":"Schulzke S, Heininger U, L\u00fccking-Famira M, Fahnenstich H: Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. Eur J Pediatr 2005; 164 (7): 432\u20135.","DOI":"10.1007\/s00431-005-1674-3"},{"key":"10.3238\/arztebl.2011.0771_ref39","doi-asserted-by":"crossref","unstructured":"Ladhani S, Slack MP, Heys M, White J, Ramsay ME: Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child 2008; 93(8): 665\u20139.","DOI":"10.1136\/adc.2007.126888"},{"key":"10.3238\/arztebl.2011.0771_ref40","doi-asserted-by":"crossref","unstructured":"Wendelboe AM, Van Rie A, Salmaso S, Englund JA: Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infectious Disease Journal 2005; 24(5)Suppl: 58\u201361.","DOI":"10.1097\/01.inf.0000160914.59160.41"},{"key":"10.3238\/arztebl.2011.0771_ref41","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: Impfung gegen humane Papillomaviren (HPV) f\u00fcr M\u00e4dchen von 12 bis 17 Jahren \u2013 Empfehlung und Begr\u00fcndung. Epid Bulletin 12\/2007: 97\u2013103."},{"key":"10.3238\/arztebl.2011.0771_ref42","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: Zus\u00e4tzliche Pertussis-Impfung im Erwachsenenalter als Tdap-Kombinationsimpfung bei der n\u00e4chsten f\u00e4lligen Td-Impfung \u2013 Empfehlung und Begr\u00fcndung. Epid Bulletin 31\/2009: 299\u2013311."},{"key":"10.3238\/arztebl.2011.0771_ref43","doi-asserted-by":"crossref","unstructured":"Wendelboe A, Hudgens M, Poole C, Van Rie A: Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerging Themes in Epidemiology 2007; 4(1): 15.","DOI":"10.1186\/1742-7622-4-15"},{"key":"10.3238\/arztebl.2011.0771_ref44","doi-asserted-by":"crossref","unstructured":"Halperin SA, Sweet L, Baxendale, et al.: How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr.Infect.Dis.J 2006; 25(3): 195\u2013200.","DOI":"10.1097\/01.inf.0000202082.56403.c4"},{"key":"10.3238\/arztebl.2011.0771_ref45","unstructured":"World Health Organization (WHO)\/UNICEF: Joint statement \u2013 Global plan for reducing measles mortality 2006\u20132010. > Programmes and projects > Immunization, Vaccines and Biologicals > IVB Document Centre > WHO\/IVB\/05.11."},{"key":"10.3238\/arztebl.2011.0771_ref46","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: \u00c4nderung der Empfehlung zur Impfung gegen Masern. Epid Bulletin 32\/2010: 315\u201321."},{"key":"10.3238\/arztebl.2011.0771_ref47","unstructured":"Mankertz A, H\u00fcl\u00dfe Ch, Tischer A: Welche Ver\u00e4nderungen f\u00fcr den Nestschutz sind bei Kindern geimpfter M\u00fctter zu erwarten? Untersuchungen zur Leihimmunit\u00e4t bei Masern, Mumps und R\u00f6teln. Kinder\u00e4rztliche Praxis 2006; 77: 10\u201318."},{"key":"10.3238\/arztebl.2011.0771_ref48","doi-asserted-by":"crossref","unstructured":"Nicoara C, Z\u00e4ch K, Trachsel D, Germann D, Matter L: Decay of passively aquired maternal antibodies against measles, mumps, and rubella viruses. Clin Diagn Lab Immunol 1999; 6(6): 868\u2013871.","DOI":"10.1128\/CDLI.6.6.868-871.1999"},{"key":"10.3238\/arztebl.2011.0771_ref49","doi-asserted-by":"crossref","unstructured":"Reuss AM, Walter D, Feig M, et al.: Influenza vaccination coverage in the 2004\/05, 2005\/06, and 2006\/07 seasons: a secondary data analysis based on billing data of the German Associations of Statutory Health Insurance Physicians. Dtsch Arztebl Int 2010; 107(48): 845\u201350.","DOI":"10.3238\/arztebl.2010.0845"},{"key":"10.3238\/arztebl.2011.0771_ref50","doi-asserted-by":"crossref","unstructured":"T\u00f6rling J, Hedlund J, Konradsen HB, Ortqvist A: Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine 2003; 22(1): 96\u2013103.","DOI":"10.1016\/S0264-410X(03)00521-8"},{"key":"10.3238\/arztebl.2011.0771_ref51","doi-asserted-by":"crossref","unstructured":"Mufson MA, Hughey DF, Turner CE, Schiffman G: Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination. Vaccine 1991; 9(6): 403\u20137.","DOI":"10.1016\/0264-410X(91)90126-Q"},{"key":"10.3238\/arztebl.2011.0771_ref52","doi-asserted-by":"crossref","unstructured":"Clifford G, Francesschi S, Diaz M, Mu\u00f1oz N, Villa LL: Chapter 3: HPV type-distribution in women with and without cervical neoplastic disease. Vaccine 2006; 24(Suppl 3): 26\u201334.","DOI":"10.1016\/j.vaccine.2006.05.026"},{"key":"10.3238\/arztebl.2011.0771_ref53","unstructured":"Robert Koch-Institut: Krebs in Deutschland 2005\/2006. H\u00e4ufigkeiten und Trends. 7. \u00fcberarbeitete Ausgabe 2010. Robert Koch-Institut (Hrsg.) und Gesellschaft der Epidemiologischen Krebsregister in Deutschland e. V. (Hrsg.): 60\u201364. > Krebsregister."},{"key":"10.3238\/arztebl.2011.0771_ref54","unstructured":"M\u00fchlhauser I, Filz M: Screening auf Zervixkarzinom. arznei-telegramm 3\/2008; 39: 29\u201338."},{"key":"10.3238\/arztebl.2011.0771_ref55","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: Impfung gegen HPV \u2013 Aktuelle Bewertung der STIKO. Epid Bulletin 32\/2009: 319\u201327."},{"key":"10.3238\/arztebl.2011.0771_ref56","unstructured":"Paul-Ehrlich-Institut: Informationen zu den Untersuchungsergebnissen der beiden Todesf\u00e4lle aus Deutschland und \u00d6sterreich. 19.2.2008. Einsehbar unter: > Information > \u00c4rzte und Apotheker > Impfungen \/ Impfstoffe > Informationen zu HPV Impfstoffen."},{"key":"10.3238\/arztebl.2011.0771_ref57","unstructured":"Deutsches \u00c4rzteblatt: . Nachrichten 9. Juni 2011."},{"key":"10.3238\/arztebl.2011.0771_ref58","doi-asserted-by":"crossref","unstructured":"Hildesheim A, Herrero R, Wacholder S, et al.: Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007; 298(7): 743\u201353.","DOI":"10.1001\/jama.298.7.743"},{"key":"10.3238\/arztebl.2011.0771_ref59","doi-asserted-by":"crossref","unstructured":"Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI: Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003; 9: 565\u201372.","DOI":"10.3201\/eid0905.020562"},{"key":"10.3238\/arztebl.2011.0771_ref60","doi-asserted-by":"crossref","unstructured":"Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al.: Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010 Jan 28; 362(4): 299\u2013305.","DOI":"10.1056\/NEJMoa0905211"},{"key":"10.3238\/arztebl.2011.0771_ref61","doi-asserted-by":"crossref","unstructured":"Clark HF, Lawley D, Matthijnssens J, DiNubile MJ, Hodinka RL: Sustained decline in cases of rotavirus gastroenteritis presenting to the Children\u2019s Hospital of Philadelphia in the new rotavirus vaccine era. Pediatr Infect Dis J. 2010; 29(8): 699\u2013702.","DOI":"10.1097\/INF.0b013e3181d73524"},{"key":"10.3238\/arztebl.2011.0771_ref62","doi-asserted-by":"crossref","unstructured":"Boom JA, Tate JE, Sahni LC, et al.: Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010; 125(2): e199\u2013207.","DOI":"10.1542\/peds.2009-1021"},{"key":"10.3238\/arztebl.2011.0771_ref63","doi-asserted-by":"crossref","unstructured":"Buttery JP, Danchin MH, Lee KJ, et al: Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29(16): 3061\u20136.","DOI":"10.1016\/j.vaccine.2011.01.088"},{"key":"10.3238\/arztebl.2011.0771_ref64","doi-asserted-by":"crossref","unstructured":"Patel MM, L\u00f3pez-Collada VR, Bulhoes, et al.: Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. NEJM 2011; 364: 2283\u201392.","DOI":"10.1056\/NEJMoa1012952"},{"key":"10.3238\/arztebl.2011.0771_ref65","unstructured":"Robert Koch-Institut: Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut: Fragen und Antworten zur M\u00f6glichkeit einer Impfung gegen Rotaviruserkrankungen. Epid Bulletin 2\/2007: 9\u201311."},{"key":"10.3238\/arztebl.2011.0771_ref66","doi-asserted-by":"crossref","unstructured":"Jit M, Edmunds WJ: Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine. 2007 May 16; 25(20): 3971\u20139.","DOI":"10.1016\/j.vaccine.2007.02.070"},{"key":"10.3238\/arztebl.2011.0771_ref67","unstructured":"Robert Koch-Institut: Stellungnahme der St\u00e4ndigen Impfkommission zur Rotavirus-Impfung. Epid Bulletin 33\/2010: 335."},{"key":"10.3238\/arztebl.2011.0771_ref68","unstructured":"Gesundes Kind: Wer bezahlt die Impfung gegen Rota-Viren? ."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T15:04:31Z","timestamp":1638803071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,11]]},"references-count":68,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2011.0771","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,11]]}}}